SCHEMBL7937071

SCHEMBL7937071

CCC1=CNNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16155294 0.74
SCHEMBL256978 0.63
SCHEMBL18699199 0.61
SCHEMBL10981439 0.59
SCHEMBL10074741 0.58
SCHEMBL10050831 0.58
SCHEMBL10370753 0.57
SCHEMBL11259921 0.57
SCHEMBL16024475 0.57
SCHEMBL18381475 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014164195-A1 TYROSINASE INHIBITORS AVON PRODUCTS, INC (US) 2014-10-09 WO disclosed
US-8394427-B2 Paxillin stimulating compositions and cosmetic uses thereof AVON PRODUCTS, INC. (US) 2013-03-12 US disclosed
US-20120328546-A1 Paxillin Stimulating Compositions and Cosmetic Uses Thereof AVON PRODUCTS, INC. (US) 2012-12-27 US disclosed
US-20110151029-A1 Paxillin Stimulating Compositions and Cosmetic Uses Thereof AVON PRODUCTS, INC. (US) 2011-06-23 US disclosed
WO-2010019391-A1 N-HETEROCYCLIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME CORP. (US) 2010-02-18 WO disclosed